Crinetics Pharmaceuticals (CRNX) Institutional Ownership

$37.48 +0.62 (+1.67%)

Closing price 02/21/2025 03:59 PM Eastern

Extended Trading

$37.47 -0.01 (-0.02%)

As of 02/21/2025 04:20 PM Eastern

Compare

Current Institutional Ownership Percentage: 98.51%
Number of Institutional Buyers (last 12 months): 142
Total Institutional Inflows (last 12 months): $1.36B

Number of Institutional Sellers (last 12 months): 71
Total Institutional Outflows (last 12 months): $448.56M

Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRNX Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2025	Mackenzie Financial Corp	5,422	$277K	0.0%	+8.8%	0.006%
2/19/2025	GF Fund Management CO. LTD.	1,947	$100K	0.0%	N/A	0.002%
2/18/2025	Castleark Management LLC	77,780	$3.98M	0.1%	+6.1%	0.084%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	325,276	$16.63M	0.0%	+19.7%	0.351%
2/17/2025	Woodline Partners LP	50,000	$2.56M	0.0%	N/A	0.054%
2/17/2025	Soleus Capital Management L.P.	85,000	$4.35M	0.3%	N/A	0.092%
2/17/2025	Two Sigma Advisers LP	8,100	$414K	0.0%	-63.8%	0.009%
2/17/2025	State of Wyoming	985	$50K	0.0%	N/A	0.001%
2/17/2025	Tema Etfs LLC	57,933	$2.96M	1.2%	N/A	0.062%
2/17/2025	Stempoint Capital LP	317,060	$16.21M	4.0%	+48.3%	0.342%
Get the Latest News and Ratings for CRNX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
2/17/2025	Rafferty Asset Management LLC	81,257	$4.16M	0.0%	-16.6%	0.088%
2/17/2025	Point72 Asset Management L.P.	2,788,939	$142.60M	0.3%	+21.2%	3.007%
2/17/2025	ProShare Advisors LLC	29,089	$1.49M	0.0%	+49.7%	0.031%
2/17/2025	MPM Bioimpact LLC	617,035	$31.55M	4.5%	+17.3%	0.665%
2/17/2025	Paradigm Biocapital Advisors LP	1,910,761	$97.70M	3.4%	-24.1%	2.060%
2/17/2025	Parkman Healthcare Partners LLC	51,133	$2.61M	0.3%	-34.1%	0.055%
2/17/2025	Nicholas Investment Partners LP	127,283	$6.51M	0.6%	+35.6%	0.137%
2/17/2025	Nuveen Asset Management LLC	527,792	$26.99M	0.0%	+2.6%	0.569%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	27,687	$1.42M	0.1%	+12.1%	0.030%
2/17/2025	Orbimed Advisors LLC	999,000	$51.08M	1.1%	-4.9%	1.077%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	53,163	$2.72M	0.0%	+14.5%	0.057%
2/17/2025	Janus Henderson Group PLC	2,795,441	$142.90M	0.1%	+15.1%	3.014%
2/17/2025	Ensign Peak Advisors Inc	502,690	$25.70M	0.0%	-18.5%	0.542%
2/17/2025	Farallon Capital Management LLC	4,075,098	$208.36M	1.1%	+250.7%	4.394%
2/17/2025	D. E. Shaw & Co. Inc.	9,876	$505K	0.0%	-85.0%	0.011%
2/17/2025	Deutsche Bank AG	211,314	$10.80M	0.0%	-2.2%	0.228%
2/17/2025	Driehaus Capital Management LLC	6,141,014	$313.99M	2.6%	+4.3%	6.622%
2/17/2025	Duquesne Family Office LLC	122,700	$6.27M	0.2%	-60.3%	0.132%
2/17/2025	Cresset Asset Management LLC	7,224	$369K	0.0%	-20.4%	0.008%
2/17/2025	Brevan Howard Capital Management LP	9,777	$500K	0.0%	N/A	0.011%
2/17/2025	Bank of America Corp DE	235,281	$12.03M	0.0%	-15.4%	0.254%
2/17/2025	BNP Paribas Financial Markets	15,259	$780K	0.0%	-27.1%	0.016%
2/17/2025	Ameriprise Financial Inc.	355,174	$18.16M	0.0%	+110.8%	0.383%
2/17/2025	Algert Global LLC	28,777	$1.47M	0.0%	-32.7%	0.031%
2/17/2025	Allostery Investments LP	9,700	$496K	0.5%	N/A	0.010%
2/17/2025	Acuta Capital Partners LLC	122,900	$6.28M	6.3%	-6.7%	0.133%
2/14/2025	Novo Holdings A S	960,215	$49.10M	3.0%	-4.0%	1.035%
2/14/2025	Jane Street Group LLC	7,404	$379K	0.0%	-94.3%	0.008%
2/14/2025	Schonfeld Strategic Advisors LLC	445,946	$22.80M	0.1%	-9.1%	0.481%
2/14/2025	First Light Asset Management LLC	885,453	$45.27M	4.3%	-6.2%	0.955%
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here.
2/14/2025	Northern Trust Corp	879,814	$44.99M	0.0%	+20.4%	0.949%
2/14/2025	The Manufacturers Life Insurance Company	148,956	$7.62M	0.0%	+11.1%	0.161%
2/14/2025	Decheng Capital LLC	167,958	$8.59M	1.8%	+6.3%	0.181%
2/14/2025	Aquatic Capital Management LLC	27,712	$1.42M	0.0%	N/A	0.030%
2/14/2025	Boothbay Fund Management LLC	137,752	$7.04M	0.2%	+25.9%	0.149%
2/14/2025	Virtus ETF Advisers LLC	1,279	$65K	0.0%	-34.8%	0.001%
2/14/2025	Gilder Gagnon Howe & Co. LLC	25,044	$1.28M	0.0%	+98.5%	0.027%
2/14/2025	Lord Abbett & CO. LLC	724,625	$37.05M	0.1%	-2.9%	0.781%
2/14/2025	Voya Investment Management LLC	389,220	$19.90M	0.0%	+0.1%	0.420%
2/14/2025	Adage Capital Partners GP L.L.C.	65,000	$3.32M	0.0%	+62.5%	0.070%
2/14/2025	Hood River Capital Management LLC	851,400	$43.53M	0.6%	+2.0%	0.918%
2/14/2025	T. Rowe Price Investment Management Inc.	1,002,882	$51.28M	0.0%	-6.1%	1.081%
2/14/2025	Price T Rowe Associates Inc. MD	5,414,505	$276.84M	0.0%	+9.5%	5.838%
2/14/2025	Diadema Partners LP	25,900	$1.32M	0.6%	N/A	0.028%
2/14/2025	Hsbc Holdings PLC	12,552	$645K	0.0%	+61.7%	0.014%
2/14/2025	Rock Springs Capital Management LP	294,100	$15.04M	0.6%	+1.6%	0.317%
2/14/2025	Tower Research Capital LLC TRC	7,412	$379K	0.0%	+1,539.8%	0.008%
2/14/2025	MetLife Investment Management LLC	53,020	$2.71M	0.0%	+18.0%	0.057%
2/14/2025	First Trust Advisors LP	195,821	$10.01M	0.0%	-6.9%	0.211%
2/13/2025	CANADA LIFE ASSURANCE Co	19,219	$981K	0.0%	+10.8%	0.021%
2/13/2025	PEAK6 LLC	10,000	$511K	0.0%	N/A	0.011%
2/13/2025	Affinity Asset Advisors LLC	460,000	$23.52M	3.1%	+15.0%	0.496%
2/13/2025	Guggenheim Capital LLC	26,143	$1.34M	0.0%	-7.2%	0.028%
2/13/2025	Barclays PLC	181,941	$9.30M	0.0%	-12.4%	0.196%
2/13/2025	Summit Investment Advisors Inc.	9,174	$469K	0.4%	+16.4%	0.010%
2/13/2025	Martingale Asset Management L P	22,484	$1.15M	0.0%	+1.9%	0.024%
2/13/2025	Legal & General Group Plc	88,939	$4.55M	0.0%	+16.4%	0.096%
2/13/2025	Invesco Ltd.	298,254	$15.25M	0.0%	+16.8%	0.322%
2/13/2025	ADAR1 Capital Management LLC	53,125	$2.72M	0.5%	-39.9%	0.057%
2/13/2025	FMR LLC	8,928,086	$456.49M	0.0%	+100.4%	9.627%
2/13/2025	Russell Investments Group Ltd.	34,200	$1.75M	0.0%	-56.0%	0.037%
2/13/2025	Envestnet Asset Management Inc.	63,077	$3.23M	0.0%	+16.1%	0.068%
2/13/2025	Wells Fargo & Company MN	100,916	$5.16M	0.0%	+18.9%	0.109%
2/12/2025	Cinctive Capital Management LP	36,988	$1.89M	0.1%	-25.2%	0.040%
2/12/2025	Bryce Point Capital LLC	22,686	$1.16M	0.3%	N/A	0.024%
2/12/2025	Headlands Technologies LLC	1,022	$52K	0.0%	N/A	0.001%
2/12/2025	Geode Capital Management LLC	2,098,841	$107.34M	0.0%	+13.6%	2.263%
2/12/2025	Franklin Resources Inc.	1,591,666	$81.38M	0.0%	+14.5%	1.716%
2/12/2025	Alliancebernstein L.P.	101,720	$5.20M	0.0%	+9.9%	0.110%
2/12/2025	Wellington Management Group LLP	6,950,567	$355.38M	0.1%	+55.9%	7.495%
2/12/2025	Schroder Investment Management Group	29,361	$1.49M	0.0%	N/A	0.032%
2/12/2025	Orion Portfolio Solutions LLC	16,721	$855K	0.0%	-8.3%	0.018%
2/12/2025	Pictet Asset Management Holding SA	848,050	$43.36M	0.0%	-6.6%	0.914%
2/12/2025	NEOS Investment Management LLC	57,933	$2.96M	0.1%	+0.9%	0.062%
2/12/2025	JPMorgan Chase & Co.	269,543	$13.78M	0.0%	-5.7%	0.291%
2/11/2025	Pier Capital LLC	111,999	$5.73M	0.8%	+3.4%	0.121%
2/11/2025	Segall Bryant & Hamill LLC	150,398	$7.69M	0.1%	N/A	0.162%
2/11/2025	Prudential Financial Inc.	277,370	$14.18M	0.0%	+60.5%	0.299%
2/11/2025	Corebridge Financial Inc.	43,599	$2.23M	0.0%	+4.8%	0.047%
2/11/2025	Vanguard Group Inc.	9,089,391	$464.74M	0.0%	+44.6%	9.801%
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here.
2/11/2025	LPL Financial LLC	6,071	$310K	0.0%	+23.7%	0.007%
2/11/2025	KLP Kapitalforvaltning AS	16,000	$818K	0.0%	N/A	0.017%
2/11/2025	Sei Investments Co.	55,727	$2.85M	0.0%	-0.8%	0.060%
2/11/2025	American Century Companies Inc.	477,298	$24.40M	0.0%	+23.4%	0.515%
2/11/2025	Teacher Retirement System of Texas	24,003	$1.23M	0.0%	+42.8%	0.026%
2/11/2025	Harvest Fund Management Co. Ltd	1,299	$66K	0.0%	N/A	0.001%
2/11/2025	Xponance Inc.	6,284	$321K	0.0%	+22.8%	0.007%
2/11/2025	Intech Investment Management LLC	43,105	$2.20M	0.1%	+92.9%	0.046%
2/10/2025	Cibc World Markets Corp	8,206	$420K	0.0%	N/A	0.009%
2/10/2025	Natixis Advisors LLC	45,683	$2.34M	0.0%	+3.0%	0.049%

(Data available from 1/1/2016 forward)

CRNX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRNX shares?: During the previous two years, 207 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($464.74M), FMR LLC ($456.49M), Wellington Management Group LLP ($355.38M), Driehaus Capital Management LLC ($313.99M), Price T Rowe Associates Inc. MD ($276.84M), Farallon Capital Management LLC ($208.36M), and State Street Corp ($145.05M).Learn more on CRNX's institutional investors.
What percentage of Crinetics Pharmaceuticals stock is owned by institutional investors?: 98.51% of Crinetics Pharmaceuticals stock is owned by institutional investors. Learn more on CRNX's institutional investor holdings.
Which institutional investors have been buying Crinetics Pharmaceuticals stock?: Of the 178 institutional investors that purchased Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.89M), Vanguard Group Inc. ($3.64M), Farallon Capital Management LLC ($3.41M), Wellington Management Group LLP ($3.36M), Jennison Associates LLC ($2.83M), Janus Henderson Group PLC ($1.80M), and Artal Group S.A. ($1.39M).

How much institutional buying is happening at Crinetics Pharmaceuticals?: Institutional investors have bought a total of 40,137,709 shares in the last 24 months. This purchase volume represents approximately $1.72B in transactions.
Which Crinetics Pharmaceuticals major shareholders have been selling company stock?: Of the 85 institutional investors that sold Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Point72 Asset Management L.P. ($5.63M), Perceptive Advisors LLC ($1.62M), Braidwell LP ($1.37M), Frazier Life Sciences Management L.P. ($1.19M), First Light Asset Management LLC ($845.42K), Paradigm Biocapital Advisors LP ($605.93K), and Wellington Management Group LLP ($555.85K).
How much institutional selling is happening at Crinetics Pharmaceuticals?: Institutional investors have sold a total of 15,061,713 shares in the last 24 months. This volume of shares sold represents approximately $589.65M in transactions.

Related Companies

This page (NASDAQ:CRNX) was last updated on 2/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crinetics Pharmaceuticals (CRNX) Institutional Ownership

CRNX Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Major Shareholders & Ownership History

CRNX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crinetics Pharmaceuticals (CRNX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

CRNX Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Major Shareholders & Ownership History

CRNX Institutional Ownership - Frequently Asked Questions

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools